February 2018 | Volume 1






More than 500 exhibiting personnel from 160 companies will be on hand. Learn how their capabilities can solve your problems and enhance your bottom line! Search the current list by capability.

In the last eight years, the gap between the number of OEM transactions vs. those in the supplier space was narrowest in 2017. What does this signify? What's prompting these transactions? Read on.





AAOS 2018 is not only the place to meet your surgeons; a number of suppliers are investing their time to get to know you and  your customers by exhibiting at AAOS.



An FDA direct final rule changes inspections from every two years to a risk-based schedule. While this does not clear the convoluted regulatory pathway for biologics, it does represent an attempt to remove inefficient policies that add to costs and reduce access without improving safety.
Early last year, ORTHOWORLD published results of an industry survey. Among the questions, we asked participants to predict: In 2017, where will the opportunities lie for you and your company? Let's look back at what happened.

Smith & Nephew reports a 97.3% decrease in hospital re-admissions following total joint reconstructions performed under eCap. The program combines Smith & Nephew implants with its wound therapy and antimicrobial dressing products.
Traditionally, the physician has been the primary customer of the device company. However, as hospitals acquire physician practices and physicians seek employment at hospitals, most device companies would admit that they really don't know their customer's new boss.